Home > Resources > Videos > Big Impact in Bio: Innovating to Save Lives

Big Impact in Bio: Innovating to Save Lives

Amgen Scholars alumni tell their #BigImpactinBio stories, focusing on how to innovate in biotechnology in order to improve and save people’s lives. Marvin Gee (ASP 2011, California Institute of Technology) is co-founder of 3T Biosciences; Ailon Haileyesus (ASP 2015, Harvard University) is a development engineer at K2M, Inc; and Joshua Yang (ASP 2013, University of California, San Diego) is co-founder of Helispot and an M.D./Ph.D. student at Johns Hopkins University.

Spotlight

Oxford BioTherapeutics

Oxford BioTherapeutics is an international biotechnology company focused on developing innovative antibody drug conjugates (ADCs) to treat cancer. Our OGAP® target discovery platform - the largest of its kind worldwide - provides a unique range of validated, novel targets identified for a wide range of cancer types. Through our collaborations with leaders in the field, such as Seattle Genetics, we have assembled each of the component technologies (Antibody- Cytotoxin/linker) to successfully develop our own pipeline of ADC's for cancer.

OTHER VIDEOS

Image analysis software for true ultra high content data on the MACSima™ Imaging System

video | July 28, 2023

Qi Tissue Image Analysis Software for the MACSima™ Imaging Platform is the key to unlocking staggering analytical ability with ultra high content imaging data generated on the revolutionary new MACSima Imaging Platform....

Watch Now

Bioprinting Living Cells: The Next Frontier in Biotechnology Technology

video | July 30, 2023

Bioprinting with living human cells is transforming healthcare as we know it. From Slurpee-like substances to molding 3D tissues, explore the cutting-edge world of 3D bioprinting. Dr. Mark Skylar-Scott from Stanford University discusses the fascinating realm of 3D bioprinting, a groundbreaking approach that goes beyond traditional plastic printing....

Watch Now

VIA Thaw™ automated dry thawer

video | May 9, 2023

VIA Thaw™ dry automated thawers give you the confidence to reliably recover cryopreserved cellular products. VIA Thaw™ L1000 intended for research or manufacturing use only is an automated dry thawer that you can use for controlled, consistent thawing of cellular products in cryobags....

Watch Now

NeatCell C-Pro application software for the Sepax™ C-Pro instrument

video | May 9, 2023

Meet the NeatCell C-Pro application. It automates the mononuclear cell fraction enrichment from diverse cellular products, and is designed for use with a density-gradient medium like Ficoll-Paque media with the Sepax C-Pro instrument and CT-90.1 single-use kit....

Watch Now

Image analysis software for true ultra high content data on the MACSima™ Imaging System

video | July 28, 2023

Qi Tissue Image Analysis Software for the MACSima™ Imaging Platform is the key to unlocking staggering analytical ability with ultra high content imaging data generated on the revolutionary new MACSima Imaging Platform....

Watch Now

Bioprinting Living Cells: The Next Frontier in Biotechnology Technology

video | July 30, 2023

Bioprinting with living human cells is transforming healthcare as we know it. From Slurpee-like substances to molding 3D tissues, explore the cutting-edge world of 3D bioprinting. Dr. Mark Skylar-Scott from Stanford University discusses the fascinating realm of 3D bioprinting, a groundbreaking approach that goes beyond traditional plastic printing....

Watch Now

VIA Thaw™ automated dry thawer

video | May 9, 2023

VIA Thaw™ dry automated thawers give you the confidence to reliably recover cryopreserved cellular products. VIA Thaw™ L1000 intended for research or manufacturing use only is an automated dry thawer that you can use for controlled, consistent thawing of cellular products in cryobags....

Watch Now

NeatCell C-Pro application software for the Sepax™ C-Pro instrument

video | May 9, 2023

Meet the NeatCell C-Pro application. It automates the mononuclear cell fraction enrichment from diverse cellular products, and is designed for use with a density-gradient medium like Ficoll-Paque media with the Sepax C-Pro instrument and CT-90.1 single-use kit....

Watch Now
MORE VIDEOS

Spotlight

Oxford BioTherapeutics

Oxford BioTherapeutics is an international biotechnology company focused on developing innovative antibody drug conjugates (ADCs) to treat cancer. Our OGAP® target discovery platform - the largest of its kind worldwide - provides a unique range of validated, novel targets identified for a wide range of cancer types. Through our collaborations with leaders in the field, such as Seattle Genetics, we have assembled each of the component technologies (Antibody- Cytotoxin/linker) to successfully develop our own pipeline of ADC's for cancer.

Events